Terence Ian Sadler

York Pharma Plc activity is acquiring, developing and commercialising prescription dermatological products. It focuses on a dermatological product called abafungin, a topical therapy intended for the treatment of fungal infections and some mixed microbial infections. The Group's product will be marketed under the trade mark Abasol. The Group's other product brands are Sabarep and Vampex. The Group operates in the United Kingdom, Japan and Germany.

Crawford Healthcare Ltd. develops, manufactures, and supplies dermatological, woundcare, and diagnostic products. It offers SunSense, QV, SilDerm, Cuplex, Chemotechnique, Zindaclin, ViTix and ViTicolor, and Chemo Nickel and Cobalt test. The company was founded in 1996 and is headquartered in Knutsford, the United Kingdom.